Ruder Finn's Kelley Yoder Named to PRWeek's Health Influencer 30 List
The recognition marks Yoder's second consecutive year on the list.
NEW YORK, Nov. 10, 2026 /PRNewswire/ -- Kelley Yoder, Managing Director and Global Head of Health and Life Sciences at Ruder Finn has been named to PRWeek's Health Influencer 30 list for the second consecutive year. Each year, PRWeek recognizes 30 influential leaders shaping the future of healthcare and pharmaceutical communications.
Yoder joined Ruder Finn in May 2026 to lead the next phase of growth for the agency's global Health and Life Sciences practice. Since joining, she has helped expand the agency's healthcare business with notable client wins in priority therapeutic areas for the agency and has helped realize organic growth across key accounts. Her focus includes building on the practice's strengths in healthcare strategy, scientific communications, corporate reputation and product marketing, while expanding how the agency applies digital, creative, and AI capabilities to client work, from early development and regulatory milestones through product launches and beyond.
"Healthcare is being reinvented and reimagined, and the Ruder Finn health practice is evolving with it," said Kelley Yoder. "By uniting deep health expertise with strategy, creative, data and AI, we're building a modern, globally connected practice designed to help clients navigate change, unlock growth and shape the future of how we communicate scientific advancements to HCPs, patients and caregivers."
"Kelley brings an incredible combination of healthcare expertise, instinct for recognizing new opportunities, and deep passion for making an impact on patients' lives" said Kathy Bloomgarden, CEO of Ruder Finn. "Since joining Ruder Finn, she's helped us grow our healthcare business, develop new client relationships and build on the strength of our global team. I'm delighted to see her leadership recognized by PRWeek."
Yoder has more than 20 years of experience advising healthcare companies on corporate and product communications. She has led communications strategies for market conditioning, product launches, FDA regulatory milestones, second-to-market introductions, corporate reputation and rebrands, as well as issues and crisis management. She also works with colleagues and clients to apply AI in healthcare communications, including a new commercial readiness approach that uses AI to anticipate market shifts, monitor for signals and changes that will impact strategies, shape globally relevant narratives, and optimize content for evolving stakeholder priorities.
About Ruder Finn
Ruder Finn is one of the world's largest independent global communications and integrated marketing agencies, leading the industry in AI strategy and implementation. Founded in 1948, Ruder Finn has defined and redefined PR for over 75 years, shaping communications that move industry-defining brands, companies, and leaders from what's now to what's next. Ruder Finn provides clients with bold strategies based on a global perspective and localized market knowledge that redefine leadership, reimagine the marketplace, and rethink customer experiences. The agency is organized around five core areas of expertise—Health Transformation, Technology Acceleration, Brand Experience, Stakeholder Relations, and Workplace of the Future—with innovative tech incubator RF TechLab providing cutting-edge predictive analytics, AI-powered creative hub RF Studio53 offering breakthrough creative, and specialized teams delivering customer-focused digital engagement. Ruder Finn has offices across North America, Asia Pacific, Europe, and the Middle East. Wholly owned agencies and offerings within Ruder Finn Group include: Ruder Finn Inc., RF Studio53, RF Engage, Touchdown, Peppercomm, RF Comunicad, Ruder Finn Atteline, Pandan Social, ERA Communications, Big Sky Communications, Missouri Creative, and The Equity Group. For more information visit www.ruderfinn.com.
Media Contact:
SOURCE Ruder Finn
Share this article